Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Cognition Therapeutics, Inc. (CGTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Cognition Therapeutics, Inc. (CGTX), most recent 12 months reported: net loss $16.77M. Latest balance sheet on file: liquid cash $34.01M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): CABALETTA BIO, INC. · CANDEL THERAPEUTICS, INC. · CERO THERAPEUTICS HOLDINGS, INC. · CULLINAN THERAPEUTICS, INC. · Calidi Biotherapeutics, Inc. · COMPASS THERAPEUTICS, INC. · MOSAIC IMMUNOENGINEERING, INC. · CEL-SCI CORPORATION

Stock screener

Watchlist